Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore

Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the repercussions of the pandemic by implementing aggressive top-down control measures and introducing immense fiscal spending. Singapore is no...

Full description

Saved in:
Bibliographic Details
Published inGlobalization and health Vol. 18; no. 1; pp. 1 - 18
Main Authors Kim, Soojin, Goh, Yuki, Kang, Jun Hong Brandon
Format Journal Article
LanguageEnglish
Published London BioMed Central 21.09.2022
BMC
Subjects
Online AccessGet full text
ISSN1744-8603
1744-8603
DOI10.1186/s12992-022-00873-x

Cover

Abstract Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the repercussions of the pandemic by implementing aggressive top-down control measures and introducing immense fiscal spending. Singapore is no exception to this trend. Owing to a whole-of-society approach, Singapore is still being lauded globally for its relatively successful record at controlling both community and trans-border spread. One notable effort by the Singapore government has taken place through its cross-sectoral collaborative partnerships with the private stakeholders behind the success. Methods/results In an attempt to better explain Singapore’s robust yet strategic response to COVID-19, this study focuses on how the experience of the SARS outbreak has informed the government’s collaborative efforts with other stakeholders in society, beyond mere transnational cooperation. Taking a comparative case study approach in the specific context of Singapore, we perform a content analysis of related government documents, mainstream newspaper articles, and academic journal articles in an inductive manner. By closely comparing two global healthcare outbreaks, we note four differences in approach. First, during the COVID-19 pandemic, Singapore has focused on securing sufficient essential healthcare resources with contingency plans to strengthen preparedness. Second, the government has actively harnessed the capacity of private entities to promote the resilience of the healthcare system and the community. Third, Singapore’s management policies have been made not only in a top-down, centralized style during the initial response stage, but also with a greater proportion of bottom-up approaches, particularly as the pandemic trudges on. More interestingly, the multi-faceted repercussions of COVID-19 have gradually opened the door to a greater variety of collaborative partnerships in sectors beyond healthcare services. The participating stakeholders include, but are not limited to, local and international business actors, non-profit organizations, academia and other countries. Lastly, as the pandemic has continued, the Singapore government has managed outward to tap the expertise and knowledge of the private sector, in particular leveraging science and technology to improve control measures and putting supportive programs into practice. Conclusion The evidence from our focused analyses demonstrates that the nature and scale of the COVID-19 pandemic produced more collaborative partnerships between the public and private sectors in Singapore as compared with the SARS outbreak. What is more, our findings offer evidence that through adaptive learning from the prior global healthcare outbreak, plus some trial and error during the initial phase of the ongoing pandemic, public- and private-sector partners, both in and outside of the healthcare service sector, have tended to “act alike,” working together to achieve a common goal. Both have been socially responsible, providing public services to people in need to promote the rapid resilience of the community, and sharing the associated risks. Overall, this study has deep and wide implications for other governments and policy makers who are still struggling to maximize essential resources and minimize the negative impacts of the healthcare crisis.
AbstractList Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the repercussions of the pandemic by implementing aggressive top-down control measures and introducing immense fiscal spending. Singapore is no exception to this trend. Owing to a whole-of-society approach, Singapore is still being lauded globally for its relatively successful record at controlling both community and trans-border spread. One notable effort by the Singapore government has taken place through its cross-sectoral collaborative partnerships with the private stakeholders behind the success. Methods/results In an attempt to better explain Singapore’s robust yet strategic response to COVID-19, this study focuses on how the experience of the SARS outbreak has informed the government’s collaborative efforts with other stakeholders in society, beyond mere transnational cooperation. Taking a comparative case study approach in the specific context of Singapore, we perform a content analysis of related government documents, mainstream newspaper articles, and academic journal articles in an inductive manner. By closely comparing two global healthcare outbreaks, we note four differences in approach. First, during the COVID-19 pandemic, Singapore has focused on securing sufficient essential healthcare resources with contingency plans to strengthen preparedness. Second, the government has actively harnessed the capacity of private entities to promote the resilience of the healthcare system and the community. Third, Singapore’s management policies have been made not only in a top-down, centralized style during the initial response stage, but also with a greater proportion of bottom-up approaches, particularly as the pandemic trudges on. More interestingly, the multi-faceted repercussions of COVID-19 have gradually opened the door to a greater variety of collaborative partnerships in sectors beyond healthcare services. The participating stakeholders include, but are not limited to, local and international business actors, non-profit organizations, academia and other countries. Lastly, as the pandemic has continued, the Singapore government has managed outward to tap the expertise and knowledge of the private sector, in particular leveraging science and technology to improve control measures and putting supportive programs into practice. Conclusion The evidence from our focused analyses demonstrates that the nature and scale of the COVID-19 pandemic produced more collaborative partnerships between the public and private sectors in Singapore as compared with the SARS outbreak. What is more, our findings offer evidence that through adaptive learning from the prior global healthcare outbreak, plus some trial and error during the initial phase of the ongoing pandemic, public- and private-sector partners, both in and outside of the healthcare service sector, have tended to “act alike,” working together to achieve a common goal. Both have been socially responsible, providing public services to people in need to promote the rapid resilience of the community, and sharing the associated risks. Overall, this study has deep and wide implications for other governments and policy makers who are still struggling to maximize essential resources and minimize the negative impacts of the healthcare crisis.
Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the repercussions of the pandemic by implementing aggressive top-down control measures and introducing immense fiscal spending. Singapore is no exception to this trend. Owing to a whole-of-society approach, Singapore is still being lauded globally for its relatively successful record at controlling both community and trans-border spread. One notable effort by the Singapore government has taken place through its cross-sectoral collaborative partnerships with the private stakeholders behind the success. Methods/results In an attempt to better explain Singapore’s robust yet strategic response to COVID-19, this study focuses on how the experience of the SARS outbreak has informed the government’s collaborative efforts with other stakeholders in society, beyond mere transnational cooperation. Taking a comparative case study approach in the specific context of Singapore, we perform a content analysis of related government documents, mainstream newspaper articles, and academic journal articles in an inductive manner. By closely comparing two global healthcare outbreaks, we note four differences in approach. First, during the COVID-19 pandemic, Singapore has focused on securing sufficient essential healthcare resources with contingency plans to strengthen preparedness. Second, the government has actively harnessed the capacity of private entities to promote the resilience of the healthcare system and the community. Third, Singapore’s management policies have been made not only in a top-down, centralized style during the initial response stage, but also with a greater proportion of bottom-up approaches, particularly as the pandemic trudges on. More interestingly, the multi-faceted repercussions of COVID-19 have gradually opened the door to a greater variety of collaborative partnerships in sectors beyond healthcare services. The participating stakeholders include, but are not limited to, local and international business actors, non-profit organizations, academia and other countries. Lastly, as the pandemic has continued, the Singapore government has managed outward to tap the expertise and knowledge of the private sector, in particular leveraging science and technology to improve control measures and putting supportive programs into practice. Conclusion The evidence from our focused analyses demonstrates that the nature and scale of the COVID-19 pandemic produced more collaborative partnerships between the public and private sectors in Singapore as compared with the SARS outbreak. What is more, our findings offer evidence that through adaptive learning from the prior global healthcare outbreak, plus some trial and error during the initial phase of the ongoing pandemic, public- and private-sector partners, both in and outside of the healthcare service sector, have tended to “act alike,” working together to achieve a common goal. Both have been socially responsible, providing public services to people in need to promote the rapid resilience of the community, and sharing the associated risks. Overall, this study has deep and wide implications for other governments and policy makers who are still struggling to maximize essential resources and minimize the negative impacts of the healthcare crisis.
The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the repercussions of the pandemic by implementing aggressive top-down control measures and introducing immense fiscal spending. Singapore is no exception to this trend. Owing to a whole-of-society approach, Singapore is still being lauded globally for its relatively successful record at controlling both community and trans-border spread. One notable effort by the Singapore government has taken place through its cross-sectoral collaborative partnerships with the private stakeholders behind the success.BACKGROUNDThe spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the repercussions of the pandemic by implementing aggressive top-down control measures and introducing immense fiscal spending. Singapore is no exception to this trend. Owing to a whole-of-society approach, Singapore is still being lauded globally for its relatively successful record at controlling both community and trans-border spread. One notable effort by the Singapore government has taken place through its cross-sectoral collaborative partnerships with the private stakeholders behind the success.In an attempt to better explain Singapore's robust yet strategic response to COVID-19, this study focuses on how the experience of the SARS outbreak has informed the government's collaborative efforts with other stakeholders in society, beyond mere transnational cooperation. Taking a comparative case study approach in the specific context of Singapore, we perform a content analysis of related government documents, mainstream newspaper articles, and academic journal articles in an inductive manner. By closely comparing two global healthcare outbreaks, we note four differences in approach. First, during the COVID-19 pandemic, Singapore has focused on securing sufficient essential healthcare resources with contingency plans to strengthen preparedness. Second, the government has actively harnessed the capacity of private entities to promote the resilience of the healthcare system and the community. Third, Singapore's management policies have been made not only in a top-down, centralized style during the initial response stage, but also with a greater proportion of bottom-up approaches, particularly as the pandemic trudges on. More interestingly, the multi-faceted repercussions of COVID-19 have gradually opened the door to a greater variety of collaborative partnerships in sectors beyond healthcare services. The participating stakeholders include, but are not limited to, local and international business actors, non-profit organizations, academia and other countries. Lastly, as the pandemic has continued, the Singapore government has managed outward to tap the expertise and knowledge of the private sector, in particular leveraging science and technology to improve control measures and putting supportive programs into practice.METHODS/RESULTSIn an attempt to better explain Singapore's robust yet strategic response to COVID-19, this study focuses on how the experience of the SARS outbreak has informed the government's collaborative efforts with other stakeholders in society, beyond mere transnational cooperation. Taking a comparative case study approach in the specific context of Singapore, we perform a content analysis of related government documents, mainstream newspaper articles, and academic journal articles in an inductive manner. By closely comparing two global healthcare outbreaks, we note four differences in approach. First, during the COVID-19 pandemic, Singapore has focused on securing sufficient essential healthcare resources with contingency plans to strengthen preparedness. Second, the government has actively harnessed the capacity of private entities to promote the resilience of the healthcare system and the community. Third, Singapore's management policies have been made not only in a top-down, centralized style during the initial response stage, but also with a greater proportion of bottom-up approaches, particularly as the pandemic trudges on. More interestingly, the multi-faceted repercussions of COVID-19 have gradually opened the door to a greater variety of collaborative partnerships in sectors beyond healthcare services. The participating stakeholders include, but are not limited to, local and international business actors, non-profit organizations, academia and other countries. Lastly, as the pandemic has continued, the Singapore government has managed outward to tap the expertise and knowledge of the private sector, in particular leveraging science and technology to improve control measures and putting supportive programs into practice.The evidence from our focused analyses demonstrates that the nature and scale of the COVID-19 pandemic produced more collaborative partnerships between the public and private sectors in Singapore as compared with the SARS outbreak. What is more, our findings offer evidence that through adaptive learning from the prior global healthcare outbreak, plus some trial and error during the initial phase of the ongoing pandemic, public- and private-sector partners, both in and outside of the healthcare service sector, have tended to "act alike," working together to achieve a common goal. Both have been socially responsible, providing public services to people in need to promote the rapid resilience of the community, and sharing the associated risks. Overall, this study has deep and wide implications for other governments and policy makers who are still struggling to maximize essential resources and minimize the negative impacts of the healthcare crisis.CONCLUSIONThe evidence from our focused analyses demonstrates that the nature and scale of the COVID-19 pandemic produced more collaborative partnerships between the public and private sectors in Singapore as compared with the SARS outbreak. What is more, our findings offer evidence that through adaptive learning from the prior global healthcare outbreak, plus some trial and error during the initial phase of the ongoing pandemic, public- and private-sector partners, both in and outside of the healthcare service sector, have tended to "act alike," working together to achieve a common goal. Both have been socially responsible, providing public services to people in need to promote the rapid resilience of the community, and sharing the associated risks. Overall, this study has deep and wide implications for other governments and policy makers who are still struggling to maximize essential resources and minimize the negative impacts of the healthcare crisis.
Abstract Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the repercussions of the pandemic by implementing aggressive top-down control measures and introducing immense fiscal spending. Singapore is no exception to this trend. Owing to a whole-of-society approach, Singapore is still being lauded globally for its relatively successful record at controlling both community and trans-border spread. One notable effort by the Singapore government has taken place through its cross-sectoral collaborative partnerships with the private stakeholders behind the success. Methods/results In an attempt to better explain Singapore’s robust yet strategic response to COVID-19, this study focuses on how the experience of the SARS outbreak has informed the government’s collaborative efforts with other stakeholders in society, beyond mere transnational cooperation. Taking a comparative case study approach in the specific context of Singapore, we perform a content analysis of related government documents, mainstream newspaper articles, and academic journal articles in an inductive manner. By closely comparing two global healthcare outbreaks, we note four differences in approach. First, during the COVID-19 pandemic, Singapore has focused on securing sufficient essential healthcare resources with contingency plans to strengthen preparedness. Second, the government has actively harnessed the capacity of private entities to promote the resilience of the healthcare system and the community. Third, Singapore’s management policies have been made not only in a top-down, centralized style during the initial response stage, but also with a greater proportion of bottom-up approaches, particularly as the pandemic trudges on. More interestingly, the multi-faceted repercussions of COVID-19 have gradually opened the door to a greater variety of collaborative partnerships in sectors beyond healthcare services. The participating stakeholders include, but are not limited to, local and international business actors, non-profit organizations, academia and other countries. Lastly, as the pandemic has continued, the Singapore government has managed outward to tap the expertise and knowledge of the private sector, in particular leveraging science and technology to improve control measures and putting supportive programs into practice. Conclusion The evidence from our focused analyses demonstrates that the nature and scale of the COVID-19 pandemic produced more collaborative partnerships between the public and private sectors in Singapore as compared with the SARS outbreak. What is more, our findings offer evidence that through adaptive learning from the prior global healthcare outbreak, plus some trial and error during the initial phase of the ongoing pandemic, public- and private-sector partners, both in and outside of the healthcare service sector, have tended to “act alike,” working together to achieve a common goal. Both have been socially responsible, providing public services to people in need to promote the rapid resilience of the community, and sharing the associated risks. Overall, this study has deep and wide implications for other governments and policy makers who are still struggling to maximize essential resources and minimize the negative impacts of the healthcare crisis.
ArticleNumber 82
Author Kang, Jun Hong Brandon
Goh, Yuki
Kim, Soojin
Author_xml – sequence: 1
  givenname: Soojin
  orcidid: 0000-0003-3141-8621
  surname: Kim
  fullname: Kim, Soojin
  email: sjkim@ntu.edu.sg
  organization: Public Policy and Global Affairs Programme, School of Social Sciences, Nanyang Technological University
– sequence: 2
  givenname: Yuki
  surname: Goh
  fullname: Goh, Yuki
  organization: Public Policy and Global Affairs Programme, School of Social Sciences, Nanyang Technological University
– sequence: 3
  givenname: Jun Hong Brandon
  surname: Kang
  fullname: Kang, Jun Hong Brandon
  organization: Public Policy and Global Affairs Programme, School of Social Sciences, Nanyang Technological University
BookMark eNp9UsFu1DAQjVCRaAs_wMkSFy4BO_Y6NgekaoGyUlElFrhatjMOXiX2YmeX8vf1biqgPfRgjT1-783TzJxVJyEGqKqXBL8hRPC3mTRSNjVuysGipfXNk-qUtIzVgmN68t_9WXWW8wZjhhmVp1X4Evc-9GiKv3XqkEY2jmMMqI96QHtf3inmXGewU0zlcxi0iUlPPoZ3aICcY8gl6hSgQy7FEa0vvq6LHFpe_1h9qIlEPqB1KaG3McHz6qnTQ4YXd_G8-v7p47fl5_rq-nK1vLiq7YK0U807C8ZpYywQya2mWrMFbbEhrbAaDGXEOltyTiwaaYzhooWOdQ4DdZQ29Lxazbpd1Bu1TX7U6Y-K2qtjIqZe6TR5O4ASzgJgoYlxjIEVRnam6SjjnMuDetF6P2ttd2aE4ixMSQ_3RO__BP9T9XGvJJO4JW0ReH0nkOKvHeRJjT5bKK0MEHdZNS3hki6EPEBfPYBu4i6F0qqCajgu3cG8oJoZdRxOAvfXDMHqsA9q3gdV9kEd90HdFJJ4QLJ-Og6ymPbD41Q6U3OpE3pI_1w9wroFIW3PLg
CitedBy_id crossref_primary_10_1177_09579265241313061
crossref_primary_10_1080_16549716_2024_2428067
crossref_primary_10_1186_s12889_024_19655_8
crossref_primary_10_1371_journal_pone_0309230
crossref_primary_10_21733_ibad_1268061
crossref_primary_10_1097_MD_0000000000041279
crossref_primary_10_4103_singaporemedj_SMJ_2023_019
crossref_primary_10_1093_ijpor_edae040
crossref_primary_10_1080_23276665_2024_2383295
crossref_primary_10_1136_bmjgh_2023_012965
crossref_primary_10_1016_j_rspp_2025_100183
crossref_primary_10_1016_j_puhe_2023_06_042
Cites_doi 10.1046/j.1440-1843.2003.00518.x
10.2196/23148
10.47102/annals-acadmedsg.V35N5p301
10.1016/j.mulfin.2005.04.010
10.1080/01436590050004373
10.47102/annals-acadmedsg.V35N6p390
10.1016/j.rpsm.2021.06.001
10.1038/s41577-021-00522-1
10.1016/j.puhe.2005.10.005
10.1177/0275074020942061
10.5694/mja2.50623
10.1002/jsc.2402
10.1016/j.jiph.2020.08.001
10.1093/pubmed/fdaa105
10.1016/j.jsis.2009.05.001
10.1007/s41748-020-00184-4
10.47102/annals-acadmedsg.2020239
10.3389/fpubh.2021.679540
10.5465/amp.2019.0023
10.47102/annals-acadmedsg.V35N5p345
10.1080/13669877.2020.1756386
10.1177/0275074020942454
10.1093/jtm/taaa159
10.11622/smedj.2020162
10.1016/S0140-6736(21)01995-4
10.1215/18752160-8698301
10.1016/j.hlpt.2020.08.015
10.1177/1049732305276687
10.1111/puar.12432
10.1007/978-4-431-55022-8_15
10.1007/978-981-15-9453-3_3
10.1080/09540962.2021.1966197
10.3390/su12125097
10.1177/135676670301000107
10.1126/science.abb4942
10.1111/j.1540-6210.2006.00665.x
ContentType Journal Article
Copyright The Author(s) 2022
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022. The Author(s).
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
M0S
M1P
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12992-022-00873-x
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1744-8603
EndPage 18
ExternalDocumentID oai_doaj_org_article_8fcee08a1bf44ec8b9db2d3466698529
PMC9490717
10_1186_s12992_022_00873_x
GeographicLocations China
Singapore
GeographicLocations_xml – name: Singapore
– name: China
GrantInformation_xml – fundername: The Ministry of Education of the Republic of Korea and the National Research Foundation of Korea
  grantid: Grant No. NRF-2018S1A3A2075609
– fundername: Ministry of Education, Singapore
  grantid: Tier 1 Grant; RG 117/20
– fundername: ;
  grantid: Grant No. NRF-2018S1A3A2075609
– fundername: ;
  grantid: Tier 1 Grant; RG 117/20
GroupedDBID ---
0R~
29I
2WC
2XV
44B
53G
5GY
5VS
7X7
7XC
88E
8C1
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABHFT
ABUWG
ACGFO
ACGFS
ACHQT
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KPI
KQ8
LMP
M1P
M48
MK0
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
AAYXX
ALIPV
CITATION
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c517t-6dcebfabbce196ca3aa45370b178caeb341cfca45f8529bbb687ed4df0e3f3323
IEDL.DBID M48
ISSN 1744-8603
IngestDate Wed Aug 27 01:29:12 EDT 2025
Thu Aug 21 18:39:55 EDT 2025
Thu Sep 04 23:47:45 EDT 2025
Thu Aug 28 08:29:55 EDT 2025
Thu Apr 24 22:58:25 EDT 2025
Tue Jul 01 03:54:13 EDT 2025
Sat Sep 06 07:27:25 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Partnerships
Cross-Sector Collaboration
Health Crisis
Singapore
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-6dcebfabbce196ca3aa45370b178caeb341cfca45f8529bbb687ed4df0e3f3323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-3141-8621
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12992-022-00873-x
PQID 2726051706
PQPubID 54663
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_8fcee08a1bf44ec8b9db2d3466698529
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9490717
proquest_miscellaneous_2716935897
proquest_journals_2726051706
crossref_primary_10_1186_s12992_022_00873_x
crossref_citationtrail_10_1186_s12992_022_00873_x
springer_journals_10_1186_s12992_022_00873_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-09-21
PublicationDateYYYYMMDD 2022-09-21
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-21
  day: 21
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Globalization and health
PublicationTitleAbbrev Global Health
PublicationYear 2022
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References 873_CR53
873_CR15
K Goh (873_CR24) 2006; 35
873_CR59
C Wong (873_CR82) 2020; 23
D Baxter (873_CR12) 2020; 12
873_CR91
J Bryson (873_CR11) 2015; 75
Z Huang (873_CR33) 2020; 8
873_CR92
W Abdullah (873_CR1) 2020; 50
873_CR90
873_CR51
873_CR50
J Henderson (873_CR31) 2004; 10
J Chen (873_CR17) 2020; 49
873_CR67
873_CR20
S Shorey (873_CR71) 2020; 42
873_CR21
Ministry of Health (873_CR58) 2020
873_CR65
873_CR26
873_CR27
873_CR68
873_CR25
V Vecchi (873_CR80) 2020; 50
873_CR62
873_CR60
873_CR61
Ministry of Finance (873_CR55) 2003
MI Chen (873_CR18) 2006; 35
Duke-NUS (873_CR22) 2020
C Tan (873_CR73) 2006; 35
A Fouda (873_CR23) 2020; 9
873_CR19
H Hsieh (873_CR32) 2005; 15
Temasek (873_CR78) 2020
CB Tay (873_CR76) 2004
873_CR77
A*STAR (873_CR3) 2020
873_CR75
873_CR37
V Pereira (873_CR66) 2020; 34
873_CR38
873_CR36
H Stevens (873_CR72) 2020; 14
873_CR4
873_CR70
873_CR2
873_CR8
873_CR9
873_CR30
873_CR74
873_CR6
873_CR7
Temasek (873_CR79) 2021
H Yi (873_CR89) 2021; 28
J Li (873_CR45) 2021; 9
M Chan-Yeung (873_CR14) 2003; 8
M Rohrer (873_CR69) 2020; 4
873_CR29
H Mutalib (873_CR64) 2000; 21
Ministry of Defence (873_CR54) 2003
Worldometers.info. (873_CR87) 2022
J Ang (873_CR5) 2006; 16
AY Lai (873_CR39) 2012; 5
873_CR88
873_CR42
873_CR86
T Carvalho (873_CR16) 2021; 21
L James (873_CR35) 2006; 120
873_CR43
873_CR48
Immigration & Checkpoints Authority (873_CR34) 2022
873_CR46
R Lin (873_CR47) 2020; 212
J Bryson (873_CR10) 2006; 66
873_CR81
A Lai (873_CR40) 2015
Q Liu (873_CR49) 2020; 13
873_CR85
873_CR83
Government Technology Agency (GovTech) (873_CR28) 2021
Ministry of Health (873_CR57) 2004
M Monti (873_CR63) 2021; 398
D Leidner (873_CR44) 2009; 18
Ministry of Foreign Affairs (873_CR56) 2021
V Martins (873_CR52) 2021; 30
L Chan (873_CR13) 2020; 10
JJ Woo (873_CR84) 2021
C Lee (873_CR41) 2020
References_xml – volume: 8
  start-page: 9
  issue: 1
  year: 2003
  ident: 873_CR14
  publication-title: Respirology
  doi: 10.1046/j.1440-1843.2003.00518.x
– ident: 873_CR25
– ident: 873_CR50
– volume: 8
  start-page: e23148
  issue: 10
  year: 2020
  ident: 873_CR33
  publication-title: JMIR Mhealth Uhealth
  doi: 10.2196/23148
– ident: 873_CR21
– volume: 35
  start-page: 301
  issue: 5
  year: 2006
  ident: 873_CR24
  publication-title: Ann Acad Med Singapore
  doi: 10.47102/annals-acadmedsg.V35N5p301
– volume: 16
  start-page: 64
  issue: 1
  year: 2006
  ident: 873_CR5
  publication-title: J Multinatl Financ Manag
  doi: 10.1016/j.mulfin.2005.04.010
– ident: 873_CR77
– volume-title: Temasek Foundation partners People's Association, corporates, unions, universities, and community organisations to provide free hand sanitiser to Singapore households
  year: 2020
  ident: 873_CR78
– ident: 873_CR15
– volume-title: Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen
  year: 2020
  ident: 873_CR22
– ident: 873_CR38
– ident: 873_CR19
– ident: 873_CR92
– volume: 5
  start-page: 74
  issue: 1
  year: 2012
  ident: 873_CR39
  publication-title: Austrian J South East Asian Stud
– volume: 21
  start-page: 313
  issue: 2
  year: 2000
  ident: 873_CR64
  publication-title: Third World Quarterly
  doi: 10.1080/01436590050004373
– ident: 873_CR86
– volume: 35
  start-page: 390
  issue: 6
  year: 2006
  ident: 873_CR18
  publication-title: Ann Acad Med Singap
  doi: 10.47102/annals-acadmedsg.V35N6p390
– ident: 873_CR2
– ident: 873_CR29
– ident: 873_CR53
  doi: 10.1016/j.rpsm.2021.06.001
– volume: 10
  start-page: 1
  issue: 2
  year: 2020
  ident: 873_CR13
  publication-title: J Glob Health
– volume-title: Minister for Foreign Affairs Dr Vivian Balakrishnan’s written replies to parliamentary questions, 26 July 2021
  year: 2021
  ident: 873_CR56
– volume: 21
  start-page: 245
  issue: 4
  year: 2021
  ident: 873_CR16
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-021-00522-1
– volume-title: Communicable diseases surveillance in Singapore 2003
  year: 2004
  ident: 873_CR57
– ident: 873_CR6
– ident: 873_CR67
– volume-title: Public-private partnerships – having the best of Both worlds
  year: 2021
  ident: 873_CR28
– volume: 120
  start-page: 20
  issue: 1
  year: 2006
  ident: 873_CR35
  publication-title: Public Health
  doi: 10.1016/j.puhe.2005.10.005
– volume-title: A collaboration to boost nationwide mask production
  year: 2020
  ident: 873_CR3
– ident: 873_CR20
– ident: 873_CR30
– ident: 873_CR51
– volume-title: Temasek review 2021: bounce forward
  year: 2021
  ident: 873_CR79
– volume: 50
  start-page: 642
  issue: 6–7
  year: 2020
  ident: 873_CR80
  publication-title: Am Rev Public Adm
  doi: 10.1177/0275074020942061
– volume: 212
  start-page: 497
  issue: 11
  year: 2020
  ident: 873_CR47
  publication-title: Med J Aust
  doi: 10.5694/mja2.50623
– ident: 873_CR59
– volume-title: Stay Home Notice (SHN) & SHN Dedicated Facilities (SDF)
  year: 2022
  ident: 873_CR34
– volume: 30
  start-page: 179
  issue: 2
  year: 2021
  ident: 873_CR52
  publication-title: Strateg Chang
  doi: 10.1002/jsc.2402
– volume: 13
  start-page: 1611
  issue: 11
  year: 2020
  ident: 873_CR49
  publication-title: J Infect Public Health
  doi: 10.1016/j.jiph.2020.08.001
– volume: 42
  start-page: 665
  issue: 4
  year: 2020
  ident: 873_CR71
  publication-title: J Public Health
  doi: 10.1093/pubmed/fdaa105
– volume: 18
  start-page: 80
  issue: 2
  year: 2009
  ident: 873_CR44
  publication-title: J Strateg Inf Syst
  doi: 10.1016/j.jsis.2009.05.001
– ident: 873_CR62
– volume: 4
  start-page: 789
  year: 2020
  ident: 873_CR69
  publication-title: Earth Syst Environ
  doi: 10.1007/s41748-020-00184-4
– ident: 873_CR83
– ident: 873_CR7
– volume: 49
  start-page: 561
  issue: 8
  year: 2020
  ident: 873_CR17
  publication-title: Ann Acad Med Singap
  doi: 10.47102/annals-acadmedsg.2020239
– volume: 9
  start-page: 679540
  year: 2021
  ident: 873_CR45
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2021.679540
– volume: 34
  start-page: 480
  issue: 4
  year: 2020
  ident: 873_CR66
  publication-title: Acad Manag Perspect
  doi: 10.5465/amp.2019.0023
– volume-title: An architecture for network centric operations in unconventional crisis: lessons learnt from Singapore's SARS experience
  year: 2004
  ident: 873_CR76
– volume-title: Comprehensive medical strategy for COVID-19
  year: 2020
  ident: 873_CR58
– ident: 873_CR75
– volume: 35
  start-page: 345
  issue: 5
  year: 2006
  ident: 873_CR73
  publication-title: Ann Acad Med Singap
  doi: 10.47102/annals-acadmedsg.V35N5p345
– volume: 23
  start-page: 1021
  issue: 7–8
  year: 2020
  ident: 873_CR82
  publication-title: J Risk Res
  doi: 10.1080/13669877.2020.1756386
– ident: 873_CR90
– ident: 873_CR36
– ident: 873_CR61
– volume: 50
  start-page: 770
  issue: 6–7
  year: 2020
  ident: 873_CR1
  publication-title: Am Rev Public Adm
  doi: 10.1177/0275074020942454
– volume: 28
  start-page: 1
  issue: 2
  year: 2021
  ident: 873_CR89
  publication-title: J Travel Med
  doi: 10.1093/jtm/taaa159
– ident: 873_CR88
– ident: 873_CR4
– ident: 873_CR27
– ident: 873_CR46
– ident: 873_CR8
– ident: 873_CR48
  doi: 10.11622/smedj.2020162
– volume: 398
  start-page: 1029
  issue: 10305
  year: 2021
  ident: 873_CR63
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(21)01995-4
– volume: 14
  start-page: 523
  issue: 3
  year: 2020
  ident: 873_CR72
  publication-title: East Asian Sci Technol Soc
  doi: 10.1215/18752160-8698301
– volume: 9
  start-page: 510
  issue: 4
  year: 2020
  ident: 873_CR23
  publication-title: Health Policy Technol
  doi: 10.1016/j.hlpt.2020.08.015
– volume: 15
  start-page: 1277
  issue: 9
  year: 2005
  ident: 873_CR32
  publication-title: Qual Health Res
  doi: 10.1177/1049732305276687
– volume: 75
  start-page: 647
  issue: 5
  year: 2015
  ident: 873_CR11
  publication-title: Public Adm Rev
  doi: 10.1111/puar.12432
– volume-title: MINDEF/SAF Personnel Recognised for Their Effort against SARS
  year: 2003
  ident: 873_CR54
– ident: 873_CR91
– start-page: 309
  volume-title: Resilience and recovery in Asian disasters
  year: 2015
  ident: 873_CR40
  doi: 10.1007/978-4-431-55022-8_15
– start-page: 49
  volume-title: Capacity-building and Pandemics
  year: 2021
  ident: 873_CR84
  doi: 10.1007/978-981-15-9453-3_3
– ident: 873_CR42
  doi: 10.1080/09540962.2021.1966197
– ident: 873_CR70
– volume: 12
  start-page: 5097
  issue: 12
  year: 2020
  ident: 873_CR12
  publication-title: Sustainability
  doi: 10.3390/su12125097
– ident: 873_CR37
– ident: 873_CR74
– volume: 10
  start-page: 67
  issue: 1
  year: 2004
  ident: 873_CR31
  publication-title: J Vacat Mark
  doi: 10.1177/135676670301000107
– volume-title: Good Public Governance in a Global Pandemic
  year: 2020
  ident: 873_CR41
– ident: 873_CR60
– ident: 873_CR85
– volume-title: COVID Live - Coronavirus statistics - worldometer
  year: 2022
  ident: 873_CR87
– ident: 873_CR65
  doi: 10.1126/science.abb4942
– volume: 66
  start-page: 44
  issue: s1
  year: 2006
  ident: 873_CR10
  publication-title: Public Adm Rev
  doi: 10.1111/j.1540-6210.2006.00665.x
– volume-title: Government Unveils $230 Million SARS Relief Package
  year: 2003
  ident: 873_CR55
– ident: 873_CR43
– ident: 873_CR26
– ident: 873_CR68
– ident: 873_CR9
– ident: 873_CR81
SSID ssj0040439
Score 2.3776288
Snippet Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the...
Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the...
The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to mitigate the...
Abstract Background The spread of COVID-19 has taken a toll on many countries and its healthcare system over the last two years. Governments have sought to...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Adaptive learning
Collaboration
Comparative studies
Content analysis
Contingency
Contingency plans
Coronaviruses
COVID-19
Cross-Sector Collaboration
Development Economics
Epidemiology
Fatalities
Global health
Health care
Health Crisis
Health in foreign policy
Health services
Health Services Research
Medicine
Medicine & Public Health
Nonprofit organizations
Outbreaks
Pandemics
Partnerships
Private sector
Public Health
Quality of Life Research
Resilience
Ridesharing
Severe acute respiratory syndrome
Singapore
Social Policy
Viral diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT0gIUR4iUJCRuIHVxHb84FYKVUEqSCxFvVm2Y8NKVRax26o_nxknWUgl4MJxEydre77xzDiebwh5LpQ1WXnN6iBqJjveMh-yZ1bFjodY8ywwOfnkgzo-le_P2rPfSn3hmbCBHniYuH2TYRmvjW9CljJFE2wXeCckuN3WtLyk7oEZm4KpYQ1Gyhg7pcgYtb8Gq4anLCHwQg42wa5mZqiw9c9czOsHJK99JS3G5-gOuT16jfRg6O0uuZH6u-TWsOVGh0yie6Q_KbsDdFNOwlJPAUwAMvp1BY9eLuE3doWtyz49nQHgFT2HFQ8ASEsVidRRTDuhi4NPC3gdPfz45d0b1li67OkCa2iD057uk9Ojt58Pj9lYToHFttEbpmA4IIYQYgK1i154L1uh69BoEz0E1bKJOcK1jPMaQlBGp052uU4iC8HFA7LTr_r0kNCgTe2N8BosPqa6ImlZanMXVdB1SrEizTS7Lo5c41jy4tyVmMMoN0jEgURckYi7qsiL7TPfB6aNv7Z-jULbtkSW7HIBsONG7Lh_Yacie5PI3ai6a8c1hnjIKlSRZ9vboHT4JcX3aXWBbZDDpjVWV0TPoDLr0PxOv_xW6LuttBhEV-TlBKpff_7nAT_6HwN-TG7yogSW8WaP7Gx-XKQn4FRtwtOiPz8BZ6ogsg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA_1-iKI-ImrVSL4pqG7m91NIoi0taUKPaVnpW8hn_Wg7NbeVfrnO5PbvbIF-7jZZDeTmUlmksxvCHnHGyVjYwTLLc9Z5cuaGRsNU43zpXV5GTkGJx9Nm8OT6ttpfbpBpkMsDF6rHObENFH7zuEe-XYp0PJGsJfPF38YZo3C09UhhYbpUyv4Twli7B7ZLDGr8oRs7u5PfxwPczNCyaghdEY22wtY7fD2JThkiM3G2fVoeUoo_iPT8_bFyVunp2lROnhEHvbWJN1Zsf8x2QjtE_JgtRVHVxFGT0l7lHYN6DLdkKWGAsFADT3roOnfOTxjV9gi7d_TkWB8pOcwE4Jg0pRdIniK4Sh0tnM8g8_Rve-_vn5hhaLzls4wtzYY8-EZOTnY_7l3yPo0C8zBeC5ZA-QAe6x1AdTRGW5MVXOR20JIZ8DZrgoXHZRFWZfKWttIEXzlYx545Lzkz8mk7drwglArZG4kNwIsAQyBRTCzUEfvGivyEFxGimF0tesxyDEVxrlOvohs9IojGjiiE0f0dUber9tcrBA47qy9i0xb10T07FTQXZ7pXhm1jGAa5NIUNlZVcNIqb0vPK3DlFNKYka2B5bpX6YW-EcCMvF2_BmXEExbThu4K6yC2TS2VyIgYicqoQ-M37fx3gvVWlULnOiMfBqG6-fn_CX55d19fkftlEm_FymKLTJaXV-E1mFFL-6bXjX9B4h4a
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA_SgggitSquthLBNw3ubrL58K09LVU4Bc9K30KSTepB2RPvKv75zmR3T7eo4ONmJ9lkZyYzk2R-IeQZl0Yn6RQrPS-ZaOuGOZ8cMzK0tQ9lnTgmJ8_fy9Mz8e68OR9gcjAX5vf9-0rLl2uwR3g-EkImRE_jDPzF3QYmXjy-N5OzcdZFkBgzJsX8sd7E8GR8_olTef1I5LV90WxuTvbIncFPpEc9Y--SG7HbJzfnw074Prndr7fRPo3oHunmeWmAbvIxWOooSBJIGL1YQSvfl_CMvWLrvEhPJ9x_RS9hugPpo_kKidhSzDmhi6OPC2iOzj58fvuaVYYuO7rAC7TBY4_3ydnJm0-zUzbcpcBCU6kNkzAy4IH3IYLOBcedEw1Xpa-UDg4ialGFFKAs6aY23nupVWxFm8rIE-c1f0B2ulUXHxLqlS6d5k6Bucc8V0Qsi01qg_SqjDEUpBp_tA0D0Djed3Fpc8Chpe2ZY4E5NjPH_ijI822drz3Mxj-pj5F_W0qEyM4FIDl20DirE9j_UrvKJyFi0N60vm65gHjN4BgLcjBy3w56u7a1wvgOIYUK8nT7GjQOt1FcF1dXSIMANo02qiBqIjWTDk3fdMsvGbvbCIMRdEFejPL16-N_H_Cj_yN_TG7VWfINq6sDsrP5dhUPwXfa-CdZaX4Cb68UMA
  priority: 102
  providerName: Springer Nature
Title Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore
URI https://link.springer.com/article/10.1186/s12992-022-00873-x
https://www.proquest.com/docview/2726051706
https://www.proquest.com/docview/2716935897
https://pubmed.ncbi.nlm.nih.gov/PMC9490717
https://doaj.org/article/8fcee08a1bf44ec8b9db2d3466698529
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfG9oKE0PgSgVEZiTcwJLHjDySE1rBpIHWglqKKl8h2nK1SlbK2Q-O_5-wkRZkG4iVSEiexfb-L72zf7xB6QbmSFdeCxIbGhJVpRrSpNFHclqmxcVpRH5w8OuUnU_Zpls12UJfuqO3A9Y2unc8nNV0tXl9d_HoPCv8uKLzkb9YwZvk9lOBWeYY1SsCm3IORKfUoH7HtqoInklFNgCQjkse0C6K58R29gSrw-feM0OtbKK-to4bh6Xgf3W3tSnzYAOEe2nH1fXSnmZTDTazRA1SPwvwB3oS9slhjgBvAEJ8t4dGfczj3VSHrMJOPexB5ixfwTwSI4pBnwpXYB6bgyeF4Aq_D-edvHz-QROF5jSc-yzb0qHuIpsdHX_MT0iZcIDZLxIZwaA4IyhjrQDGtplqzjIrYJEJaDW43S2xl4Vols1QZY7gUrmRlFTtaUZrSR2i3XtbuMcJGyFhLqgXYBD4Y1tOauawqLTcids5GKOl6t7AtG7lPirEoglciedFIpACJFEEixVWEXm6f-dFwcfyz9NALbVvS82iHC8vVWdGqZSErMBJiqRNTMeasNKo0aUkZOHXKtzFCB53Iiw6bRSq8E-h5hyL0fHsb1NKvtejaLS99Gc9yk0klIiR6UOlVqH-nnp8Hgm_FlHezI_SqA9Wfj_-9wU_-ozJP0e00YFyRNDlAu5vVpXsGVtXGDNAtMRNwlHkyQHvDo9MvYzjLeT4I8xSDoEpwHA-__wb-TCUt
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqcgAJIZ4itICR4ARWEzsPGwmhsqXapd0isS3qzdiOU1aqkra7hfKn-I3MOJutUoneekxiJ47n4Rl75htCXotcySo3BYutiFla8owZWxmmcldy62JeCUxOHu_lw4P0y2F2uEL-drkwGFbZ6cSgqMvG4R75Bi_Q8kawl48npwyrRuHpaldCo2WLHf_nN7hssw-jLaDvG863P-8PhmxRVYA56D5neek8jMZa54H7nBHGpJkoYpsU0hnwLdPEVQ7uVTLjylqby8KXaVnFXlRCINABqPxbmGmEciUHy5ASBKpRXWKOzDdmsJZibCe4e4j8JthFb_ELNQJ6hu3VsMwrZ7Nhydu-T-4tbFW62TLXA7Li64fkbrvRR9v8pUekHoc9CToP8bfUUJhOmCt61EDXX1O4xqGwWTgdoD22e0-PQc8C29NQu8KXFJNd6GTz2wReRwdfv4-2WKLotKYTrNwNroJ_TA5uZLqfkNW6qf1TQm0hYyOFKcDOwARbhErzWVW63Bax9y4iSTe72i0QzrHQxrEOno7MdUsRDRTRgSL6IiJvl31OWnyPa1t_QqItWyI2d7jRnB3phahrWYHhEUuT2CpNvZNWlZaXIgVHUeE_RmS9I7leKIyZvmTviLxaPgZRx_MbU_vmHNsgck4mVRGRoscqvQH1n9TTnwE0XKUKXfeIvOuY6vLj___hZ9eP9SW5Pdwf7-rd0d7OGrnDA6srxpN1sjo_O_fPwWCb2xdBSij5cdNi-Q_SzFc0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ha9UwEA-ywRBEdCpWp0bwm4a1TdskfptvPjb1TfE52beQpMn2YPSNvW7453uXtk87VPBj0yRNenfJXe7uF0Je8UrJUBnBUstTVtR5yYwNhqnK1bl1aR44JifPjqqD4-LDSXnyWxZ_jHYfXJJdTgOiNDXt7kUdOhGX1e4KdimMmgRDCjHVOAMtchOxuhA9f1JNhrUYoWPUkCrzx3aj7Sii9o9UzZuBkje8pXETmt4jd3vtke515L5Pbvlmm2zNev_4NrnTncLRLrnoAWlm8cCAtjE4lhoKUwW-o6dL6OV6Ac84KraKR_d0xBNv6TksgsCTNF4s4WuKmSh0vvd1Dt3Ryefvh_ssU3TR0Dleqw16vH9Ijqfvv00OWH_DAnNlJlpWwcyAMtY6D5LoDDemKLlIbSakM2BnF5kLDsqCLHNlra2k8HVRh9TzwHnOH5GNZtn4x4RaIVMjuRGgBGD2K-KY-TLUrrIi9d4lJBt-tHY9_DjegnGuoxkiK90RRwNxdCSO_pGQ1-s2Fx34xj9rv0P6rWsicHYsWF6e6l4OtQygFaTSZDYUhXfSqtrmNS_AilM4x4TsDNTXvTSvdC7Q6kOgoYS8XL8GOUTnimn88grrIKxNKZVIiBhxzWhA4zfN4iwieqtCoV2dkDcDf_36-N8n_OT_qr8gW1_2p_rT4dHHp-R2HoVAsTzbIRvt5ZV_BspVa59H-fkJCakfbw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Moving+toward+a+common+goal+via+cross-sector+collaboration%3A+lessons+learned+from+SARS+to+COVID-19+in+Singapore&rft.jtitle=Globalization+and+health&rft.au=Kim%2C+Soojin&rft.au=Goh%2C+Yuki&rft.au=Kang%2C+Jun+Hong+Brandon&rft.date=2022-09-21&rft.issn=1744-8603&rft.eissn=1744-8603&rft.volume=18&rft.issue=1&rft.spage=82&rft_id=info:doi/10.1186%2Fs12992-022-00873-x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1744-8603&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1744-8603&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1744-8603&client=summon